LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific (EUFI.PA), the world leader in bioanalytical testing, plans to mark its 30th anniversary by donating €1 million to 40 charities selected by its global workforce. This donation will be in addition to its long-term and ongoing support for several non-governmental organizations (NGOs) including UNICEF and Plan International.
The €1 million donation will target charities that work in areas that, like Eurofins’ testing of foods and pharmaceutical products and of the environment, help make the planet a safer and healthier place to live. The recipient charities fall into five categories: better nutrition, protecting ecosystems, improving health, social entrepreneurship and local communities.
In addition to this financial support, many members of Eurofins’ 30,000-strong workforce will pledge time to volunteer, offer pro bono work and organise events to support their chosen good causes. In each country, volunteer committees were actively involved in choosing organisations that are important to their local area and close to their hearts.
Dr. Gilles Martin, CEO of Eurofins, said: “There is no better way for Eurofins to celebrate its 30th anniversary than sharing some of the results of our success with organizations and initiatives that work to preserve our environment, improve the health and safety of all worldwide, and support the less fortunate.”
He went on to say: “I am fortunate to lead a Company that makes every day a positive contribution to health around the world, and to work with so many leaders, entrepreneurs and team members who share the same passion – advancing science and testing technologies towards a better and safer life for all. Beyond the contribution of our everyday work to this inspiring objective, it is pleasing that our commercial success enables us to support non-profit organisations who also work for these causes.”
He pointed out this donation is in addition to the company’s regular annual donations.
Highlighted below is an example from each country/region of the 40 total initiatives supported by Eurofins and its employees that span across all continents:
In the US, Eurofins’ employees picked Water for People, which works across 9 countries to bring safe water and sanitation to 4 million people.
In Europe, Eurofins is proud to back Médecins Sans Frontières’ (MSF) Mini-lab project, which is developing cheap and portable clinical laboratories to support MSF’s doctors conduct epidemic investigations in developing countries. Eurofins will also co-fund and support the Nutri’Zaza project, which seeks to combat chronic child malnutrition in Madagascar by producing and distributing an affordable highly nutritious food supplement.
In Japan, Eurofins will make a donation to Save Fukushima Orphans, which is dedicated to supporting orphans of the Great East Japan Earthquake. Eurofins also operates a radioactivity measurement competence centre there to assist the local community in assessing the impact of radioactivity linked to the Fukushima disaster.
Our employees in the Nordic region selected the Swedish Society for Nature Conservation (SSNC), which will receive a contribution for its work to protect the marine environment of the Baltic Sea, which is under threat from over fishing, pollutants, micro plastics and eutrophication. Eurofins will also become a partner of the SSNC and share our expertise in analytical testing services to support their environmental work.
In Brazil, Eurofins will donate to Amigos do Bem, an organisation that promotes local development and social inclusion through self-sustaining projects and education efforts.
The additional initiatives supported by Eurofins include:
In Europe, Eurofins will make donations to the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Foundation Gustave Roussy, to Médecins Sans Frontières (MSF) Mini-Lab project, to UNICEF’s “Clean water saves lives” project, to the German Red Cross’s “Food Security Project”, to the Deutscher Kinderhospizverein e.V. (DKHV), to the Duke of Edinburgh (DoE) award, to Allergy UK, to the British Science Association, to the Special Education School of San Rafael, to the Asociación Niños con trasplante hepático (ANiNATH) and to the Federación Española de Bancos de Alimentos, to the EAT Forum, to the Danish organization Walking for Water, to T-Celleforskning, to the Swedish Society for Nature Conservation (SSNC), to Barcode for Life, to Bart de Graaff Foundation for their BIKKELS project, to the Dungarvan branch of the Irish Red Cross, to the South East Simon Community and to the National Children’s Hospital in Tallaght.
In the Americas, Eurofins will make donations to Amigos do Bem, to Americares, to the Conservation Fund, to the Community Action Partnership of Lancaster County, to the Gift of Life Foundation, to the Water for People charity and to the United Service Organizations (USO).
In the APAC region, Eurofins will make donations to the Save Fukushima Orphans project, to the You Dao Foundation, to the Oasis Green Food Bank, to the World Wildlife Fund (WWF) of China, to KidsCan New Zealand, to the Tindall Foundation and to OzHarvest.
For more information, please visit www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter sometimes “Eurofins” or “the Group”) believes it is the world leader in food, environment and pharmaceutical products testing and that it is also one of the global independent market leaders in certain testing and laboratory services for agroscience, genomics, discovery pharmacology and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With over 30,000 staff in 400 laboratories across 41 countries, Eurofins offers a portfolio of over 150,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group objective is to provide its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgment of Eurofins Scientific’s management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.